Positive late-stage study results position the company to file for clearance of what could be the first narcolepsy drug that ...

Abrams Realty & Development recently submitted revised plans for the Exton Square Mall site project in West Whiteland, with feedback from officials ...

Abrams Realty & Development said its new plans in West Whiteland include the removal of dozens of proposed townhouses, six ...

Takeda boosts profit margins with AI-driven growth, FY2024 guidance upgrade, share buyback plan & promising drug launches.

Abrams Realty & Development says its mixed-use Exton Square plan is "about transforming a broken mall." Exton Square Mall under contract with buyer eyeing redevelopment Pennsylvania lawmaker seeks ...

Takeda Pharmaceutical said on Thursday its CEO Christophe Weber will retire after more than a decade at the helm of Japan's biggest drugmaker as the company upped its full-year profit outlook.

The journey of Takeda’s gout med Uloric—which turned rocky in recent years—has come to an end in the U.S. This week, the medicine, first approved in 2009, was listed as discontinued on the ...

Global biopharmaceutical giant Takeda opens its first Asian Innovation Capability Centre in Bengaluru to speed-up drug discovery and development.

Following a series of layoff rounds this year, Takeda is once again pruning its headcount in the Bay State. | As part of a new round of layoffs, certain Takeda staffers at two Massachusetts sites ...

Pharmaceutical giant Takeda is closing its San Diego office at 9625 Towne Centre Drive. The local unit called Takeda Ventures focused on research and development.

Takeda has made some cuts to its clinical-phase pipeline, hacking off midphase programs and early-stage prospects as part of a push to focus on its most promising candidates. | Takeda has taken an ...

Biotech Takeda drops cancer candidates, axing immunocytokine and CAR-Ts amid shifting treatment landscape By Nick Paul Taylor Feb 2, 2024 5:33am Takeda Oncology cell therapy Cell & Gene Therapy ...